Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Agile Therapeutics, Inc. AGRX
$5.05
-$0.56 (-11.09%)
На 18:00, 12 мая 2023
-80.20%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
5201221.00000000
-
week52high
141.00
-
week52low
5.22
-
Revenue
10884000
-
P/E TTM
0
-
Beta
1.08581300
-
EPS
-56.41000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 10:59
Описание компании
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Maxim Group | Buy | Hold | 26 июл 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 11 июл 2022 г. |
| Maxim Group | Hold | Buy | 08 апр 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 03 ноя 2021 г. |
| HC Wainwright & Co. | Buy | Buy | 13 сент 2021 г. |
| HC Wainwright & Co. | Buy | Buy | 30 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Butch Jason | A | 6000 | 6000 | 09 ноя 2022 г. |
| Welsh Amy | A | 10000 | 10000 | 09 ноя 2022 г. |
| Korner Paul | A | 10000 | 10000 | 09 ноя 2022 г. |
| Gilmore Geoffrey | A | 10000 | 10000 | 09 ноя 2022 г. |
| Conway Robert G | A | 10000 | 10000 | 09 ноя 2022 г. |
| ALTOMARI ALFRED | A | 30000 | 30000 | 09 ноя 2022 г. |
| ALTOMARI ALFRED | A | 64343 | 50000 | 26 авг 2022 г. |
| Carson Sandra | A | 807 | 807 | 09 июн 2022 г. |
| Carson Sandra | A | 1952 | 670 | 09 июн 2022 г. |
| BARBARI SHARON | A | 807 | 807 | 09 июн 2022 г. |
Новостная лента
Agile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023
GlobeNewsWire
08 мая 2023 г. в 08:00
PRINCETON, N.J., May 08, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report first quarter 2023 financial results after the market close on Thursday, May 11, 2023.
Agile Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on Wednesday, March 22, 2023
GlobeNewsWire
21 мар 2023 г. в 09:05
Live Conference Call and Webcast at 4:30 p.m. ET Live Conference Call and Webcast at 4:30 p.m. ET
TEVA Beats Q4 Earnings Estimates, Sales Miss & Stock Down
Zacks Investment Research
09 февр 2023 г. в 09:48
TEVA reports mixed Q4 results, beating earnings estimates, while sales slightly miss estimates. Stock down post earnings release.
Agile Therapeutics To Present At The Upcoming RHK Capital Disruptive Growth Conference
GlobeNewsWire
01 дек 2022 г. в 08:30
PRINCETON, N.J., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it will participate in the RHK Capital Disruptive Growth Conference being held in the offices of Reed Smith in New York, NY on December 5-6, 2022. Chairman and Chief Executive Officer Al Altomari will present a corporate overview at the conference on Monday, December 5 at 3:20 p.m. ET.
Agile Therapeutics, Inc. (AGRX) Q3 2022 Earnings Call Transcript
Seeking Alpha
07 ноя 2022 г. в 18:59
Agile Therapeutics, Inc. (NASDAQ:AGRX ) Q3 2022 Results Conference Call November 7, 2022 4:30 PM ET Company Participants Matthew Riley - Head of Investor Relations Alfred Altomari - Chairman and Chief Executive Officer Amy Welsh - Chief Commercial Officer Jason Butch - Chief Accounting Officer Conference Call Participants Oren Livnat - H.C. Wainwright Nazibur Rahman - Maxim Group LLC Operator Good afternoon, and welcome to the Agile Therapeutics Third Quarter 2022 Financial Results Conference Call.